210 related articles for article (PubMed ID: 29350614)
1. LIPG signaling promotes tumor initiation and metastasis of human basal-like triple-negative breast cancer.
Lo PK; Yao Y; Lee JS; Zhang Y; Huang W; Kane MA; Zhou Q
Elife; 2018 Jan; 7():. PubMed ID: 29350614
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of LIPG phospholipase activity suppresses tumor formation of human basal-like triple-negative breast cancer.
Lo PK; Yao Y; Zhou Q
Sci Rep; 2020 Jun; 10(1):8911. PubMed ID: 32488004
[TBL] [Abstract][Full Text] [Related]
3. Identification of biomimetic nanoplatform-mediated delivery of si-ISG15 for treatment of triple-negative breast cancer.
Wang F; Zhang N; Niu R; Lu Y; Zhang W; He Z
Cell Signal; 2024 Jun; 118():111117. PubMed ID: 38401776
[TBL] [Abstract][Full Text] [Related]
4. Endothelial cells promote triple-negative breast cancer cell metastasis
Zhang W; Xu J; Fang H; Tang L; Chen W; Sun Q; Zhang Q; Yang F; Sun Z; Cao L; Wang Y; Guan X
FASEB J; 2018 Jan; 32(1):276-288. PubMed ID: 28899878
[TBL] [Abstract][Full Text] [Related]
5. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
[TBL] [Abstract][Full Text] [Related]
6. FAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple negative breast cancer cells.
Taliaferro-Smith L; Oberlick E; Liu T; McGlothen T; Alcaide T; Tobin R; Donnelly S; Commander R; Kline E; Nagaraju GP; Havel L; Marcus A; Nahta R; O'Regan R
Oncotarget; 2015 Mar; 6(7):4757-72. PubMed ID: 25749031
[TBL] [Abstract][Full Text] [Related]
7. Negative regulation of ISG15 E3 ligase EFP through its autoISGylation.
Zou W; Wang J; Zhang DE
Biochem Biophys Res Commun; 2007 Mar; 354(1):321-7. PubMed ID: 17222803
[TBL] [Abstract][Full Text] [Related]
8. Covalent ISG15 conjugation to CHIP promotes its ubiquitin E3 ligase activity and inhibits lung cancer cell growth in response to type I interferon.
Yoo L; Yoon AR; Yun CO; Chung KC
Cell Death Dis; 2018 Jan; 9(2):97. PubMed ID: 29367604
[TBL] [Abstract][Full Text] [Related]
9. A Proof-of-Concept Inhibitor of Endothelial Lipase Suppresses Triple-Negative Breast Cancer Cells by Hijacking the Mitochondrial Function.
Yang R; Han S; Clayton J; Haghighatian M; Tsai CC; Yao Y; Li P; Shen J; Zhou Q
Cancers (Basel); 2022 Aug; 14(15):. PubMed ID: 35954428
[TBL] [Abstract][Full Text] [Related]
10. NUMB negatively regulates the epithelial-mesenchymal transition of triple-negative breast cancer by antagonizing Notch signaling.
Zhang J; Shao X; Sun H; Liu K; Ding Z; Chen J; Fang L; Su W; Hong Y; Li H; Li H
Oncotarget; 2016 Sep; 7(38):61036-61053. PubMed ID: 27506933
[TBL] [Abstract][Full Text] [Related]
11. Emodin inhibits epithelial‑mesenchymal transition and metastasis of triple negative breast cancer via antagonism of CC‑chemokine ligand 5 secreted from adipocytes.
Song X; Zhou X; Qin Y; Yang J; Wang Y; Sun Z; Yu K; Zhang S; Liu S
Int J Mol Med; 2018 Jul; 42(1):579-588. PubMed ID: 29693154
[TBL] [Abstract][Full Text] [Related]
12. Integrin α5 down-regulation by miR-205 suppresses triple negative breast cancer stemness and metastasis by inhibiting the Src/Vav2/Rac1 pathway.
Xiao Y; Li Y; Tao H; Humphries B; Li A; Jiang Y; Yang C; Luo R; Wang Z
Cancer Lett; 2018 Oct; 433():199-209. PubMed ID: 29964204
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer.
Di L; Liu LJ; Yan YM; Fu R; Li Y; Xu Y; Cheng YX; Wu ZQ
J Exp Clin Cancer Res; 2019 Mar; 38(1):134. PubMed ID: 30898152
[TBL] [Abstract][Full Text] [Related]
14. PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells.
Byerly J; Halstead-Nussloch G; Ito K; Katsyv I; Irie HY
Breast Cancer Res; 2016 Sep; 18(1):95. PubMed ID: 27663795
[TBL] [Abstract][Full Text] [Related]
15. The oncogenic STP axis promotes triple-negative breast cancer via degradation of the REST tumor suppressor.
Karlin KL; Mondal G; Hartman JK; Tyagi S; Kurley SJ; Bland CS; Hsu TY; Renwick A; Fang JE; Migliaccio I; Callaway C; Nair A; Dominguez-Vidana R; Nguyen DX; Osborne CK; Schiff R; Yu-Lee LY; Jung SY; Edwards DP; Hilsenbeck SG; Rosen JM; Zhang XH; Shaw CA; Couch FJ; Westbrook TF
Cell Rep; 2014 Nov; 9(4):1318-32. PubMed ID: 25453754
[TBL] [Abstract][Full Text] [Related]
16. Quercetin regulates β-catenin signaling and reduces the migration of triple negative breast cancer.
Srinivasan A; Thangavel C; Liu Y; Shoyele S; Den RB; Selvakumar P; Lakshmikuttyamma A
Mol Carcinog; 2016 May; 55(5):743-56. PubMed ID: 25968914
[TBL] [Abstract][Full Text] [Related]
17. AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer.
Chen B; Wang J; Dai D; Zhou Q; Guo X; Tian Z; Huang X; Yang L; Tang H; Xie X
J Exp Clin Cancer Res; 2017 May; 36(1):65. PubMed ID: 28494797
[TBL] [Abstract][Full Text] [Related]
18. ISG15 disrupts cytoskeletal architecture and promotes motility in human breast cancer cells.
Desai SD; Reed RE; Burks J; Wood LM; Pullikuth AK; Haas AL; Liu LF; Breslin JW; Meiners S; Sankar S
Exp Biol Med (Maywood); 2012 Jan; 237(1):38-49. PubMed ID: 22185919
[TBL] [Abstract][Full Text] [Related]
19. Covalent ISG15 conjugation positively regulates the ubiquitin E3 ligase activity of parkin.
Im E; Yoo L; Hyun M; Shin WH; Chung KC
Open Biol; 2016 Aug; 6(8):. PubMed ID: 27534820
[TBL] [Abstract][Full Text] [Related]
20. Deptor enhances triple-negative breast cancer metastasis and chemoresistance through coupling to survivin expression.
Parvani JG; Davuluri G; Wendt MK; Espinosa C; Tian M; Danielpour D; Sossey-Alaoui K; Schiemann WP
Neoplasia; 2015 Mar; 17(3):317-28. PubMed ID: 25810016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
